Results 181 to 190 of about 3,329,974 (215)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Innovative Blended Learning Curriculum in Noninvasive Ventilation for Pulmonary and Critical Care Fellows

open access: yesAvicenna Journal of Medicine
Asil Daoud   +3 more
doaj   +1 more source

Life-Cycle Assessment of Nd-Fe-B Rare Earth Magnet Production. [PDF]

open access: yesACS Omega
Prados TM   +2 more
europepmc   +1 more source

Comparative Usability Evaluation of Two Hospital Information Systems: A Mixed-Methods Study in an Iranian Teaching Hospital. [PDF]

open access: yesHealth Sci Rep
Mousavi AS   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy